Most studies seeking to target NRP1 function have assessed a candidate agent's ability to modulate endothelial cell phenotypes in commonly used in vitro assays and/or examined their ability to inhibit tumour growth and angiogenesis in mouse models. Here, NRP1 is linked to neoplasm.